Palantir stock is once again a top performer across the S&P 500 and Nasdaq-100, but a sharp sell-off could be in store sooner ...

Despite all of the uncertainty surrounding the capital markets, some stocks continue to rack up gains in 2025. One of the ...

Two of the most covered stocks this year are Palantir and UnitedHealth Group, but the reasons why couldn't be further apart.

Despite a sharp drop in FCF yield and valuation froth, Palantir's growth potential justifies a bullish outlook, similar to ...

Palantir enjoyed a sharp rise. But with a performance boost also comes portfolio concentration headaches across several funds ...

Palantir stock rallied to a new all-time high Wednesday, driven by recent positive developments. Today, the stock is ...

While Palantir's momentum looks tempting and UnitedHealth's scandals may spook investors away, valuation trends between these two stocks show a compelling case as to which is the better buy right now.

Shares of Palantir Technologies (NASDAQ:PLTR) gained 0.24% over the past five trading days, bringing its one-month gain to 12 ...

Palantir and Snowflake (NYSE: SNOW) are both high-growth software companies. Palantir stock has been a stellar performer over the past twelve months, rising by over 500%, compared to Snowflake, which ...

Since the end of 2022, shares of Palantir have returned nearly 1,900%, which has lifted the company's market cap to north of ...

Though AI is an enormous addressable opportunity, it doesn't mean all cutting-edge AI stocks are worth investing in.

Palantir Technologies (NasdaqGS:PLTR) has experienced significant momentum, with a 62% share price increase over the last quarter, fueled by a series of impactful partnerships. The company formed a ...